CD8A and neoplasm: However, treatment with PF, as well as the combination therapy, significantly enhanced CD8+ T-cell infiltration in tumor tissues of tumor-bearing mice (P < 0.01) These findings indicate that PF enhanced T-cell infiltration in tumor tissues following Sor treatment (Fig. 3 A & B).